Method for manufacturing nitrogen-containing carbon alloy, nitrogen-containing carbon alloy, and fuel cell catalyst
US-2015376218-A1 · Dec 31, 2015 · US
US9742011B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9742011-B2 |
| Application number | US-201414776777-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 17, 2014 |
| Priority date | Mar 15, 2013 |
| Publication date | Aug 22, 2017 |
| Grant date | Aug 22, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A family of customizable tethering molecules for tethering cofactors such as, but not necessarily limited to, nicotinamine adenine dinucleotide (NAD+/NADH, NAD(P)+/NAD(P)H) to substrates or structures formed from or including graphene-like materials is described. The tethered cofactor can then be used, for example, as biosensors employed for clinical diagnostic, food industry, medical drug development and environmental and military applications, as well as in reagentless biofuel cells for power generation.
Opening claim text (preview).
What is claimed is: 1. A complex formed from a NAD/(P)+/NAD(P)H cofactor tethered to a graphene-like material selected from the group consisting of multi-walled carbon nanotubes, single walled carbon nanotubes, graphene, rGO, and other graphene-based or graphene-containing substrates, wherein the cofactor is attached, via a covalent bond, to a pyrene butanoic acid succinimidyl ester tethering molecule which is attached to the graphene-like material via π-π stacking. 2. The complex of claim 1 wherein the graphene-like material is a multi-walled carbon nanotube (MWCNT). 3. The complex of claim 1 further comprising a protein which requires the presence of the cofactor for biological function tethered to the graphene-like material. 4. The complex of claim 3 wherein the protein is an enzyme. 5. The complex of claim 3 wherein the protein is a biocatalyst. 6. A method for forming a biological complex comprising: covalently attaching a NAD(P)+/NAD(P)H cofactor to a pyrene butanoic acid succinimidyl ester tethering enzyme and; attaching the tethering enzyme to a graphene-like material selected from the group consisting of multi-walled carbon nanotubes, single walled carbon nanotubes, graphene, rGO, and other graphene-based or graphene-containing substrates via π-π stacking. 7. The method of claim 6 further comprising tethering a protein that interacts with the NAD(P)+/NAD(P)H confactor to the graphene-like material. 8. The method of claim 7 wherein the protein is an enzyme. 9. The method of claim 7 wherein the protein is a biocatalyst.
Dinucleotides, e.g. nicotineamide-adenine dinucleotide phosphate · CPC title
Multi-walled nanotubes · CPC title
Enzymes or microbial cells immobilised on or in an organic carrier · CPC title
Chemistry & Metallurgy · mapped topic
Selection of catalytic material · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.